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Abstract
Background Developmental delay may be due to a variety of 
factors occurring during the prenatal, perinatal, or postnatal 
periods, one of which is hyperbilirubinemia.
Objective To evaluate the impact of hyperbilirubinemia on infant 
developmental delay. 
Methods A prospective cohort study was conducted from March to 
-XO\6XEMHFWVZHUHORZELUWKZHLJKWLQIDQWVZLWKDQGZLWKRXW
hyperbilirubinemia. Developmental delay was measured using the 
Mullen Scales of Early Learning'DWDZDVDQDO\]HGE\&KLVTXDUH
test and relative risks were calculated. Logistic regression analysis 
was performed to assess factors associated with developmental 
delay. Differences were considered statistically significant for P 
YDOXHV
Results)RUW\VL[ORZELUWKZHLJKWLQIDQWVZHUHHQUROOHG
LQWKLVVWXG\ZLWKK\SHUELOLUXELQHPLDDQGZLWKRXW
hyperbilirubinemia. The relative risk (RR) for developmental 
GHOD\LQWKHK\SHUELOLUXELQHPLDJURXSZDV&,WR
0XOWLYDULDWHDQDO\VLVUHYHDOHGWKDWK\SHUELOLUXELQHPLDGLG
QRWVLJQLILFDQWO\LQIOXHQFHGHYHORSPHQWDOGHOD\55&,
WR+RZHYHUVPDOOIRUJHVWDWLRQDODJHZLWKRUZLWKRXW
hyperbilirubinemia significantly influenced developmental delay 
55&,WR
Conclusion Hyperbilirubinemia in low birth weight infants is 
not a risk factor for developmental delay at the age of 3 months. 
However, being small for gestational age with or without 
hyperbilirubinemia significantly influences the likelihood of 
developmental delay. [Paediatr Indones. 2013;53:228-31.].
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A
FFRUGLQJWRWKH ,QGRQHVLDQ+HDOWK
Demographic Survey (Survey Demografi 
dan Kesehatan Indonesia), the incidence of 
ORZELUWKZHLJKW/%:ZDVAt Dr. Sardjito 
Hospital, the prevalence of newborn jaundice was 
GHILQHGDVELOLUXELQOHYHOVLQFUHDVLQJWR!
PJG/7KHLQFLGHQFHRIMDXQGLFHLQSUHPDWXUHLQIDQWV
ZDVDQGWKDWRIK\SHUELOLUXELQHPLDZDV
Hyperbilirubinemia and LBW are risk factors for 
developmental delay.3 Hyperbilirubinemia in LBW 
EDELHVLVPRUHVHYHUHDQGUHTXLUHVPRUHLQWHQVLYH
treatment compared to normal infants, due to 
immature red blood cells, liver, and gastrointestinal 
system.+\SHUELOLUXELQHPLDLQ/%:
JUDPVLVGHILQHGDVVHUXPELOLUXELQOHYHOVRI!PJ
G/RQILUVWGD\RIOLIH!PJG/RQWKHVHFRQGGD\
!PJG/RQWKHWKLUGGD\DQG!PJG/RQ
the fourth day.Cognitive developmental delay in 
LBW infants is related to the level of reduced birth 
weight. Emotional and behavioral delays may also 
be present in infants with LBW.HyperbilirubinemiaWiradharma et al: 'HYHORSPHQWDOGHOD\LQPRQWKROGORZELUWKZHLJKWLQIDQWVZLWKK\SHUELOLUXELQHPLD
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complications happen if unconjugated bilirubin enters 
the brain, causing brain damage. The blood brain 
barrier is the primary protection for brain, but bilirubin 
may reach the blood brain barrier, leading to bilirubin 
encephalopathy. Bilirubin encephalopathy may be 
IDWDORUFDXVHQHXURORJLFDOVHTXHODHDQGKHDULQJ
loss in surviving infants.%LOLUXELQQHXURWR[LFLW\
may induce dysfunction, ranging from mild cognitive 
LPSDLUPHQWDQGK\SHUNLQHVLVWRVHYHUHVHTXHODH
We aimed to evaluate the risk of developmental 
delay in low birth weight infants with and without 
hyperbilirubinemia, at the age of 3 months.
Methods
We performed a prospective, cohort study in the 
Perinatology Ward at Sanglah Hospital from March
WR-XO\:HVFUHHQHGDOOLQIDQWVZLWK/%:
,QFOXVLRQFULWHULDZHUHK\SHUELOLUXELQHPLDLQWKH
ILUVWGD\VRIOLIH'HQSDVDUUHVLGHQWDQGDYDLODELOLW\
RISDUHQWDOLQIRUPHGFRQVHQW:HH[FOXGHGLQIDQWV
with intracranial infection, head injury, brain tumor, 
UDGLDWLRQH[SRVXUHGXULQJSUHJQDQF\RUJHQHWLF
abnormalities. Reasons for dropping out of the study 
were neonatal seizure, parental refusal to join the 
study, or subjects moving to an unreachable address. 
0LQLPXPVDPSOHVL]HZDVFDOFXODWHGWRREWDLQ
SRZHUVLJQLILFDQFHOHYHO3DQGFOLQLFDO
GLIIHUHQFHV7KHUHZHUH/%:LQIDQWVZLWK
K\SHUELOLUXELQHPLDDQGZLWKRXWK\SHUELOLUXELQH
mia. Developmental delay was measured using the 
Mullen Scales of Early Learning, American Guidance 
Service (AGS) Edition, as the primary outcome in our 
VXEMHFWVDWWKHDJHRIPRQWKVGXULQJDIROORZXSYLVLW
at the clinic. Parents were contacted for appointment 
WLPHVDWWKHFOLQLF,IDSDUHQWPLVVHGWKHDSSRLQWPHQW
the authors conducted a home visit. 
'DWDZDVDQDO\]HGE\ELYDULDWH&KLVTXDUHDQG
multivariate (multiple logistic regression) analyses. A 
3YDOXHRIZLWKFRQILGHQFHLQWHUYDO&,
was considered to be statistically significant. This 
study was approved by the Ethics Committee and 
Research Department of Udayana University Medical 
6FKRRO6DQJODK*HQHUDO+RVSLWDO
Results
6WXG\VXEMHFWVFRQVLVWHGRI/%:LQIDQWVRI
ZKLFKZHUHIHPDOH0HGLDQJHVWDWLRQDODJH
head circumference, body length, and albumin level, 
as well as other basic characteristics of subjects are 
shown in Table 1. We found that hyperbilirubinemia 
Table 1. Characteristics of study subjects with LBW
Characteristics Hyperbilirubinemia
(n=23)
Without hyperbilirubinemia
(n=23)
Median gestational age (range), weeks 
    Premature, n
    Full term, n
Median head circumference (range), cm 
Median body length (range), cm 
Male gender, n
No severe asphyxia, n
Median weight, grams (interquartile range)
    Normal for gestational age, n
    Small for gestational age, n 
Median serum albumin level (range), g/dL 
    35.0 (32-40)
    15
      8 
    31.0 (28-33) 
    44.0 (39-48)
    14
    23 
2000.0 (1450-2400)
    14
      9 
      3.7 (3.0-4.1)
    36.0 (34-39)
    16 
      7
    31.0 (29-33)
    44.0 (40-48)
    13
    23
2250.0 (1800-2450)
    18 
      5 
      3.7 (2.5-4.7)
Table 2. Relative risk of developmental delay in LBW babies with hyperbilirubinemia
Variable Developmental delay
(n=17)
Normal development
(n=35)
RR 95% CI P value*
Hyperbilirubinemia, n 7 16
Without hyperbilirubinemia, n 4 15 2.08 0.51 to 8.40 0.30
* Chi squre testWiradharma et al: 'HYHORSPHQWDOGHOD\LQPRQWKROGORZELUWKZHLJKWLQIDQWVZLWKK\SHUELOLUXELQHPLD
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was not a risk factor for developmental delay
(Table 2). Further analysis by multivariate logistic 
regression test showed that small for gestational 
age was significantly associated with developmental 
delay, but hyperbilirubinemia was not (Table 3).
Discussion
Studies on the effect of hyperbilirubinemia on infant 
development have yielded inconsistent results.   
Developmental delay in premature infants with 
hyperbilirubinemia has been reported to be higher 
compared to that of normal infants. The risk of gross 
motor delay was found to be increased in  full term 
babies with hyperbilirubinemia. Hyperbilirubinemia 
was also found to be a risk factor for developmental 
delay at the age of 3 months, but prematurity and 
LBW were not.
+\SHUELOLUXELQHPLDPD\FDXVHGHOD\HGGHYHORS
ment when a large amount of unconjugated bilirubin 
in the blood passes through the blood brain barrier, 
then conjugates with the brain phospolipid membrane, 
causing neuron damage. Bilirubin also elicits 
QHXURH[FLWDWRU\VLJQDOVDQGQHUYHFRQGXFWLRQ
especially in the auditory nerve, leading to neural 
hearing loss and impaired or delayed speech.
%LOLUXELQFRQFHQWUDWLRQDQGGXUDWLRQRIH[SRVXUHDOVR
worsened the damage.
,QRXUVXEMHFWVGHYHORSPHQWDOGHOD\ZDVQRW
influenced by hyperbilirubinemia. However, we 
found that the risk for developmental delay in LBW
LQIDQWVZDVWLPHVKLJKHULQVPDOOIRUJHVWDWLRQDO
age than in normal for gestational age infants. This 
result contrasts with that from a previous study 
perhaps due to different study design, measurement 
tools, and analysis.Hyperbilirubinemia was found 
to not be a risk factor for autism in children.,Q
infants with hyperbilirubinemia whose development 
ZDVODWHUWHVWHGDWWKHDJHRI\HDUVQRVLJQLILFDQW
effect was observed. Also, there was no correlation 
between peak total serum bilirubin and hearing loss.
Furthermore, there was no relationship found between 
hyperbilirubinemia and delayed speech in premature 
children. Satish et al. found no significant differences 
for gestational age, birth weight, serum albumin, and 
total bilirubin between normal babies and babies with 
hearing loss.
We also found that hyperbilirubinemia was not a 
risk factor for developmental delay. However, albumin 
PD\DOWHUWKHHIIHFWVRIELOLUXELQ,IXQFRQMXJDWHG
bilirubin is totally bound to albumin, there would 
EHQRIUHHELOLUXELQLQWKHEORRG,QGLUHFWELOLUXELQ
in fat could pass through the blood brain barrier by 
diffusion, particularly if albumin capacity to bind 
bilirubin and protein plasma was reduced.Therefore,
albumin concentration in blood is strongly related to 
bilirubin in plasma.
Multivariate analysis in our study revealed a 
significant difference in birth weight cateegories, as 
the risk of developmental delay at 3 months of age 
was higher in small for gestational age LBW subjects. 
Oh et al. found that the risk of developmental delay 
and health complications increased for LBW babies.
Bilirubin encephalopathy in LBW infants occurred 
at higher level bilirubin concentrations, and these 
infants had poor prognoses (death). Those who 
survived had neurological impairments, such as 
developmental delay and hearing loss.
A limitation of our study was that we did not 
measure the blood osmolality, which may influence 
ELOLUXELQWR[LFLW\2WKHUIDFWRUVSRWHQWLDOO\DIIHFWLQJ
development, such as stimulation, nutrition, 
environment, and prenatal factors also were not 
HYDOXDWHGLQRXUVWXG\,QDGGLWLRQWKHVDPSOH
population was limited to those residing in Denpasar, 
and measurement of developmental delay was 
SHUIRUPHGRQO\RQFH,QFRQFOXVLRQK\SHUELOLUXELQH
mia is not a risk factor for developmental delay in 
LBW infants, however, small gestational age with 
or without hyperbilirubinemia is a risk factor for 
developmental delay in our subjects at the age of 3 
months.
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Table 3. Multivariate analysis (logistic regression) of 
factors associated with developmental delay at the age of 
3 months 
Variables RR 95% CI P value
Small for gestational age 12.13 2.43 to 60.56 0.02
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